Skip to content

Opticyte

The World’s Only Cell O₂ Monitor

  • Technology
  • About Us
  • Investors
  • Health Equity
  • News
  • Contact Us

Category: News

  • All
  • All
News

Opticyte Selected for MedTech Accelerator 2023 Cohort

Posted on June 12, 2023
News

Opticyte Earns FDA Breakthrough Device Designation for the First Cell O2 Patient Monitor for Organ Failure

Posted on January 9, 2023Last Updated: February 25, 2023
News

CEO Lori Arakaki on Working with StarFish Medical

Posted on November 16, 2022Last Updated: February 25, 2023
News

Pacific Northwest Sepsis Conference

Posted on April 29, 2021Last Updated: February 25, 2023
News

CEO Lori Arakaki on Creating Successful Academic Spin-outs

Posted on February 17, 2021Last Updated: February 25, 2023
News

GeekWire: UW spinout Opticyte lands $4.6M to test device that quickly detects early signs of organ failure

Lisa Stiffler, GeekWirePosted on January 13, 2021Last Updated: February 25, 2023
News

Opticyte Secures $4.6 Million in Funding to Develop First Cell O2 Monitor for Reducing Organ Failure

Posted on January 13, 2021Last Updated: February 25, 2023
News

Opticyte: Why the Need is Now

Lori Arakaki, CEO & Co-founderPosted on December 11, 2020Last Updated: May 27, 2024
  • 1
  • 2
  • 3
Connect.
  • Follow us on:
  • Facebook
  • LinkedIn

Stay Informed

Find out first about important updates and announcements by signing up to our newsletter.


Opticyte

Opticyte, Inc.
4000 Mason Road, Suite 300
Seattle, WA 98195

Contact Us
  • Technology
  • News
  • About Us
  • Careers
  • Investors
  • Conflict of Interest Policy

Opticyte, Inc.
4000 Mason Road, Suite 300
Seattle, WA 98195


© 2025 Opticyte. All rights reserved.

Website Designed and Built by Wildern Design + Interactive

  • Home
  • Technology
  • About Us
  • Investors
  • News
  • Contact Us